highly significantP = 0.007
EU infants, was shown to be highly significant ( P = 0.007).
EU infants, was shown to be highly significant ( P = 0.007).
KIR2DL2/KIR2DL2 IP infants had a strong trend of lower representation of homozygous KIR2DL2 compared to EU infants ( P = 0.052; OR = 0.16), and this trend was maintained post MVL adjustment ( Table 2: P = 0.058; OR = 0.13).
Upon correction for MVL, Bx20 only showed a trend ( P = 0.09; OR = 0.17) of lower representation in TR mothers vs.
KIR2DL3/KIR2DL3+C2C2 A weak trend of increased representation of homozygous KIR2DL3 in the absence of its' HLA-C ligand (i.e. homozygous C2 group) in the IP infants compared to the EU infants was noted ( P = 0.086; OR = 2.87).